Fulcrum Therapeutics (FULC) EBITDA Margin (QoQ) (2020 - 2023)
Fulcrum Therapeutics (FULC) EBITDA Margin (QoQ) (2020 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Fulcrum Therapeutics |
267.90 Mn |
267.90 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2023 |
40,151.00 |
| Sep 30, 2023 |
-51,392.00 |
| Jun 30, 2023 |
636,982.00 |
| Mar 31, 2023 |
-538,754.00 |
| Dec 31, 2022 |
-202,490.00 |
| Sep 30, 2022 |
-24,961.00 |
| Jun 30, 2022 |
-78,209.00 |
| Mar 31, 2022 |
-55,662.00 |
| Dec 31, 2021 |
-4,907.00 |
| Sep 30, 2021 |
2,724.00 |
| Jun 30, 2021 |
-9,360.00 |
| Mar 31, 2021 |
6,519.00 |
| Dec 31, 2020 |
60,860.00 |
| Sep 30, 2020 |
-25,124.00 |
| Jun 30, 2020 |
168,978.00 |
